🇺🇸 FDA
Patent

US 8454972

Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 8454972 (Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/545, A61K2039/57